Christie + Co
Essential reading for the healthcare business
Remember me:
Skip Navigation LinksHealthInvestor article
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.

Posted on: 26/09/2011

Latest news stories

PegasusLife has acquired fellow retirement living developer and provider Renaissance Retirement, a move that more than doubles its portfolio of developments to 71 sites.
Spire Healthcare has confirmed its financial expectations for the full year 2017, with underlying ebitda of between £149 million and £151 million, down from £162 million in 2016.
The spending gap between NHS mental health services and NHS acute hospitals widened further last year, research published today has indicated.
Octopus Healthcare’s open-ended UK healthcare real estate fund has raised £85 million in January 2018.
Glenholme Healthcare Group, an established provider of learning disabilities and mental health care services for adults and young people, is expanding into elderly care for the first time.


Christie + Co

HealthInvestor Events

Political U-turns, tussles over sleep-ins, and a bumper year for investment in retirement villages - HealthInvestor UK reflects on 2017
Read more

interview: Steve Gray

In a stagnant UK independent hospital market, Nuffield Health CEO Steve Gray is confident that he has got his company moving along the right track. Ploy Radford finds out more
Read more

HealthInvestor blog
2017 has provided some sobering thought for investors but there has been renewed interest in the market to celebrate too

Click here to view the Editor's blog

In a stagnant UK independent hospital market, Nuffield Health CEO Steve Gray is confident that he has got his company moving along the right track. Ploy Radford finds out more
Retail guru, The Vet chair and avid traveller
Candesic’s Dr Niklas Jahn and Dr Michelle Tempest suggest a silver lining for investors in the drug discovery and biotech space
Local authority reliance on independent fostering agencies is increasing, find Clare Connell and Henry Hunt of Connell Consulting
CQC chief inspector of adult social care, Andrea Sutcliffe, tells Ploy Radford how the regulator sees its role and why it’s “doing it even better than before”

Click here to search all feature articles